Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca appoints Professor Nazneen Rahman to its Board of Directors and Science Committee
-
AstraZeneca delivers new data on expanding portfolio of cancer medicines at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Bydureon EXSCEL trial meets primary safety objective in type-2 diabetes patients at wide range of cardiovascular risk
-
Phase III ZONDA trial for benralizumab shows ability to reduce oral steroid use in severe asthma patients
-
AstraZeneca enters agreement with Recordati for Seloken in Europe
-
Brodalumab receives positive CHMP opinion for the treatment of adult patients with moderate-to-severe plaque psoriasis
-
AstraZeneca to present scientific advancements from growing respiratory portfolio at the American Thoracic Society conference 2017
-
Imfinzi significantly reduces the risk of disease worsening or death in the Phase III PACIFIC trial for Stage III unresectable lung cancer
-
AstraZeneca provides update on STRATOS 1 Phase III trial of tralokinumab in severe, uncontrolled asthma
-
AstraZeneca and Pieris Pharmaceuticals collaborate to develop and commercialise Anticalin-based inhaled treatments for respiratory diseases
Latest articles and press releases
All of our latest press releases and articles are available to explore
